BridgeMD
Tests treatment safety and results for Metabolic Syndrome
Official title The Effectiveness of Intermittent Fasting, Caloric Restriction and Physical Activity On Metabolic Syndrome
ClinicalTrials.gov ID: NCT07181655
What this study is testing
- What it's testing
- Metabolic syndrome (MetS) is a global health issue defined by a cluster of risk factors-abdominal obesity, elevated blood pressure, high fasting blood sugar, high triglycerides, and low HDL cholesterol-that together significantly increase the risk of cardiovascular disease, type 2 diabetes, and overall mortality. Globally, about 20-25% of adults are affected, but prevalence varies by region and population; in Saudi Arabia, studies report rates ranging from 28.3% to 56.4%, with higher rates observed in northern and central regions and among men.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- The will be adult aged 18 years and above who have three or more of the following five risk factors (Kunduraci \& Ozbek, 2020):
- Abdominal obesity.
- Elevated triglycerides.
- Low HDL cholesterol.
- Elevated blood pressure.
You likely can't join if
- Being pregnant, lactating women.
- Diagnosis of cardiac failure or/and severe renal or liver diseases, cancer.
- Having had bariatric surgery.
- Physical or mental disability.
- Neurological or cognitive impairment.
- Participant with severely impaired vision, hearing, or speech.
See the full eligibility criteria
- The will be adult aged 18 years and above who have three or more of the following five risk factors (Kunduraci \& Ozbek, 2020):
- Abdominal obesity.
- Elevated triglycerides.
- Low HDL cholesterol.
- Elevated blood pressure.
- Elevated fasting blood glucose.
- Being pregnant, lactating women.
- Diagnosis of cardiac failure or/and severe renal or liver diseases, cancer.
- Having had bariatric surgery.
- Physical or mental disability.
- Neurological or cognitive impairment.
- Participant with severely impaired vision, hearing, or speech.
- Following a special diet or having changed their dietary pattern within the previous 12 weeks of the study's start date.
- Use of insulin or sulphonamide derivative oral antidiabetic drugs.
- Conditions that will seriously affect weight management such as having had bariatric surgery.
The study team makes the final eligibility decision.
Where it's taking place
- Serdang, Selangor, Malaysia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Serdang, Selangor, Malaysia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.